Developing Resilience

Resiliency – is defined as the ability to recover from disruptive change, misfortune, and failure. In the face of a major health crisis of our own or our loved ones, resiliency is possible.

Here are some suggestions for developing resiliency, as excerpted from The Leadership Secrets of Hillary Clinton by Rebecca Shambaugh, McGraw-Hill

Understand Yourself. Resiliency is built on self-awareness. This includes knowledge of your values, beliefs, emotions, and attitudes as well as your strengths and weaknesses.

Control Your Immediate Response and Make a Plan. We all tend to have an immediate reaction to adversity. Some of us avoid the bad news while others prepare for battle. Know your tendency to react one way or the other, and choose to be pro-active rather than reactive.

Embrace Change because it will help build new skills, broaden your perspective, and enhance your resilience.

Be Courageous. Fear causes us to become immobile, ignore options, and retreat from possibility. It is the greatest obstacle to resiliency. Courage might mean standing up for what you believe is important, or even volunteering to do something that you're not really sure you can do.

Never Give Up! We all get discouraged, but this is when we need to dig deep inside and find that well of determination and inner strength that will help us face our fears, and keep us committed to our goals.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap